These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 30458320)

  • 1. Allogeneic hematopoietic stem cell transplantation for the treatment of BCR-ABL1-negative atypical chronic myeloid leukemia and chronic neutrophil leukemia: A retrospective nationwide study in Japan.
    Itonaga H; Ota S; Ikeda T; Taji H; Amano I; Hasegawa Y; Ichinohe T; Fukuda T; Atsuta Y; Tanizawa A; Kondo T; Miyazaki Y
    Leuk Res; 2018 Dec; 75():50-57. PubMed ID: 30458320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allogeneic stem cell transplantation in patients with atypical chronic myeloid leukaemia: a retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation.
    Onida F; de Wreede LC; van Biezen A; Eikema DJ; Byrne JL; Iori AP; Schots R; Jungova A; Schetelig J; Finke J; Veelken H; Johansson JE; Craddock C; Stelljes M; Theobald M; Holler E; Schanz U; Schaap N; Bittenbring J; Olavarria E; Chalandon Y; Kröger N
    Br J Haematol; 2017 Jun; 177(5):759-765. PubMed ID: 28369779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Allogeneic transplantation as a therapeutic option for atypical chronic myeloid leukemia].
    Itonaga H
    Rinsho Ketsueki; 2024; 65(9):967-975. PubMed ID: 39358297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic neutrophilic leukemia and atypical chronic myeloid leukemia: 2024 update on diagnosis, genetics, risk stratification, and management.
    Szuber N; Orazi A; Tefferi A
    Am J Hematol; 2024 Jul; 99(7):1360-1387. PubMed ID: 38644693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Progress in Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia.
    Dao KT; Tyner JW; Gotlib J
    Curr Hematol Malig Rep; 2017 Oct; 12(5):432-441. PubMed ID: 28983816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSF3R mutated myeloid neoplasms: Beyond chronic neutrophilic leukemia.
    Mohamed A; Gao J; Chen YH; Abaza Y; Altman J; Jennings L; Vormittag-Nocito E; Sukhanova M; Lu X; Chen Q
    Hum Pathol; 2024 Jul; 149():66-74. PubMed ID: 38879086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
    Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of CSF3R mutations in atypical chronic myeloid leukemia and other myeloid malignancies.
    Kim SY; Song IC; Kim J; Kwon GC
    Ann Diagn Pathol; 2024 Aug; 71():152317. PubMed ID: 38642470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allogeneic transplantation: a therapeutic option for myelofibrosis, chronic myelomonocytic leukemia and Philadelphia-negative/BCR-ABL-negative chronic myelogenous leukemia.
    Mittal P; Saliba RM; Giralt SA; Shahjahan M; Cohen AI; Karandish S; Onida F; Beran M; Champlin RE; de Lima M
    Bone Marrow Transplant; 2004 May; 33(10):1005-9. PubMed ID: 15048141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment efficacy of imatinib mesylate versus allogeneic hematopoietic stem cell transplantation for patients with chronic myeloid leukemia in chronic phase].
    Gao GL; Xu N; Zhou X; Xiao YJ; Ding L; Lu QS; Wei YQ; Zhang Y; Xu D; Sun J; Liu QF; Liu XL
    Zhonghua Yi Xue Za Zhi; 2013 Oct; 93(38):3035-9. PubMed ID: 24417923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of hematopoietic stem cell transplantation in patients with atypical chronic myeloid leukemia.
    Koldehoff M; Beelen DW; Trenschel R; Steckel NK; Peceny R; Ditschkowski M; Ottinger H; Elmaagacli AH
    Bone Marrow Transplant; 2004 Dec; 34(12):1047-50. PubMed ID: 15516946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Impact of HLA compatibility on the outcome of allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia].
    ZHANG Y; CHEN YK; FAN ZP; XU D; JIANG QL; SUN J; LIU QF
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Mar; 31(3):438-42. PubMed ID: 21421478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic neutrophilic leukemia: novel mutations and their impact on clinical practice.
    Tefferi A; Elliott M; Pardanani A
    Curr Opin Hematol; 2015 Mar; 22(2):171-6. PubMed ID: 25575036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic Transplantation in Chronic Myeloid Leukemia and the Effect of Tyrosine Kinase Inhibitors on Survival: A Quasi-Experimental Study.
    Özen M; Üstün C; Öztürk B; Topçuoğlu P; Arat M; Gündüz M; Atilla E; Bolat G; Arslan Ö; Demirer T; Akan H; İlhan O; Beksaç M; Gürman G; Özcan M
    Turk J Haematol; 2017 Mar; 34(1):16-26. PubMed ID: 27094579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of unrelated cord blood transplantation and HLA-matched sibling hematopoietic stem cell transplantation for patients with chronic myeloid leukemia in advanced stage.
    Zheng C; Tang B; Yao W; Tong J; Zhu X; Song K; Geng L; Liu H; Sun Z
    Biol Blood Marrow Transplant; 2013 Dec; 19(12):1708-12. PubMed ID: 24060407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical Chronic Myeloid Leukemia: Where Are We Now?
    Crisà E; Nicolosi M; Ferri V; Favini C; Gaidano G; Patriarca A
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Allogeneic hematopoietic stem cell transplantation for acute myeloblastic leukemia in first remission].
    Bondarenko SN; Semenova EV; Vavilov VN; Stancheva NV; Morozova EV; Alianskiĭ AL; Babenko EV; Osipova NÉ; Zubarovskaia LS; Afanas'ev BV
    Ter Arkh; 2013; 85(7):18-25. PubMed ID: 24137943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Allogeneic hematopoietic stem cell transplantation for treatment of Philadelphia chromosome positive acute lymphoblastic leukemia].
    Xu LP; Huang XJ; Liu KY; Chen H; Liu DH; Zhang YC; Chen YH; Han W; Gao ZY; Lu DP
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Jun; 37(3):231-5. PubMed ID: 15968308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How I treat atypical chronic myeloid leukemia.
    Gotlib J
    Blood; 2017 Feb; 129(7):838-845. PubMed ID: 27899359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Impact of Donor Source on Allogeneic Hematopoietic Stem Cell Transplantation Outcomes in Adults with Chronic Myelomonocytic Leukemia: A Nationwide Retrospective Analysis in Japan.
    Itonaga H; Aoki K; Aoki J; Ishikawa T; Ishiyama K; Uchida N; Sakura T; Ohashi K; Kurokawa M; Ozawa Y; Matsuoka KI; Nakamura Y; Kimura F; Iwato K; Nawa Y; Hirokawa M; Kato K; Ichinohe T; Atsuta Y; Miyazaki Y
    Biol Blood Marrow Transplant; 2018 Apr; 24(4):840-848. PubMed ID: 29196081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.